These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33668216)

  • 1. Identification of Host Factors Associated with the Development of Equine Herpesvirus Myeloencephalopathy by Transcriptomic Analysis of Peripheral Blood Mononuclear Cells from Horses.
    Zarski LM; Giessler KS; Jacob SI; Weber PSD; McCauley AG; Lee Y; Soboll Hussey G
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33668216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses.
    Giessler KS; Goehring LS; Jacob SI; Davis A; Esser MM; Lee Y; Zarski LM; Weber PSD; Hussey GS
    J Gen Virol; 2024 May; 105(5):. PubMed ID: 38767608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia.
    Wilsterman S; Soboll-Hussey G; Lunn DP; Ashton LV; Callan RJ; Hussey SB; Rao S; Goehring LS
    Vet Microbiol; 2011 Apr; 149(1-2):40-7. PubMed ID: 21093993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 and IgG4/7 mucosal antibodies.
    Eady NA; Holmes C; Schnabel C; Babasyan S; Wagner B
    J Virol; 2024 Jun; 98(6):e0025024. PubMed ID: 38742875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation parameters following equine herpesvirus type 1 infection in horses.
    Wilson ME; Holz CL; Kopec AK; Dau JJ; Luyendyk JP; Soboll Hussey G
    Equine Vet J; 2019 Jan; 51(1):102-107. PubMed ID: 29658149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
    Burgess BA; Tokateloff N; Manning S; Lohmann K; Lunn DP; Hussey SB; Morley PS
    J Vet Intern Med; 2012; 26(2):384-92. PubMed ID: 22332764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the immune response to the pathogenesis of equine herpesvirus-1 (EHV-1): Are there immune correlates that predict increased risk or protection from EHV-1 myeloencephalopathy?
    Hussey GS; Giessler KS
    Vet J; 2022 Apr; 282():105827. PubMed ID: 35405348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection of central nervous system endothelial cells by cell-associated EHV-1.
    Goehring LS; Hussey GS; Ashton LV; Schenkel AR; Lunn DP
    Vet Microbiol; 2011 Mar; 148(2-4):389-95. PubMed ID: 20884134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection.
    Zarski LM; Weber PSD; Lee Y; Soboll Hussey G
    Pathogens; 2021 Jan; 10(1):. PubMed ID: 33430330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma D-dimer concentrations during experimental EHV-1 infection of horses.
    Goehring LS; Soboll Hussey G; Gomez Diez M; Benedict K; Maxwell LK; Morley PS; Sloet van Oldruitenborgh-Oosterbaan MM; Lunn DP
    J Vet Intern Med; 2013; 27(6):1535-42. PubMed ID: 24112533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
    Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
    Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between equine herpesvirus-1 viremia and abortion or equine herpesvirus myeloencephalopathy in domesticated horses: A systematic review.
    Soboll-Hussey G; Dorman DC; Burgess BA; Goehring L; Gross P; Neinast C; Osterrieder K; Pusterla N; Lunn DP
    J Vet Intern Med; 2024; 38(3):1872-1891. PubMed ID: 38069576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
    Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of equine herpesvirus myeloencephalopathy - Is heparin a novel option? A case report.
    Walter J; Seeh C; Fey K; Bleul U; Osterrieder N
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2016 Oct; 44(5):313-317. PubMed ID: 27652372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equine Herpesvirus Type 1 Modulates Cytokine and Chemokine Profiles of Mononuclear Cells for Efficient Dissemination to Target Organs.
    Pavulraj S; Kamel M; Stephanowitz H; Liu F; Plendl J; Osterrieder N; Azab W
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32911663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine Herpesvirus-1 Myeloencephalopathy.
    Pusterla N; Hussey GS; Goehring LS
    Vet Clin North Am Equine Pract; 2022 Aug; 38(2):339-362. PubMed ID: 35811201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine Herpesvirus-1 Myeloencephalopathy, an Emerging Threat of Working Equids in Ethiopia.
    Negussie H; Gizaw D; Tessema TS; Nauwynck HJ
    Transbound Emerg Dis; 2017 Apr; 64(2):389-397. PubMed ID: 26010868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains.
    Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN
    Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
    Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
    BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.